Legend Biotech Corp.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
Latest on Legend Biotech Corp.
Once almost written-off, GSK ’s Blenrep now looks like a practice-changing therapy for patients with relapsed/refractory multiple myeloma, after the company unveiled impressive Phase III overall surv
The data that Gilead Sciences subsidiary Kite and Arcellx presented at the American Society of Hematology meeting for anitocabtagene autoleucel (anito-cel) were positive, but the question that remains
The dizzying array of new treatments for multiple myeloma is set to become even more complex in the near future, and a new platform trial aims to get a better handle on how the variety of drugs with d
Going global, including through licensing out deals, is the only approach for Chinese biotech companies to survive now and in the following decade. At least this was a key message from the China biote